NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC.

Authors

Eleftherios Mamounas

Eleftherios P. Mamounas

National Surgical Adjuvant Breast and Bowel Project (NSABP), and the UF Health Cancer Center at Orlando Health, Orlando, FL

Eleftherios P. Mamounas , Julia R. White , Hanna Bandos , Thomas B. Julian , Atif J. Kahn , Simona Flora Shaitelman , Mylin Ann Torres , Susan Ann McCloskey , Frank A. Vicini , Patricia A. Ganz , Soonmyung Paik , Nilendu Gupta , Joseph P. Costantino , Walter John Curran , Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Local Therapy

Clinical Trial Registration Number

NCT01872975

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS1141)

DOI

10.1200/jco.2014.32.15_suppl.tps1141

Abstract #

TPS1141

Poster Bd #

230B

Abstract Disclosures